Noom Med vs Hims & Hers
$149/mo against $238/mo for tirzepatide. Which is worth it, and for whom.
Updated 2026-09-18
How we are paid: one company on this page — Coreage Rx — pays us a commission if you sign up through our link. It does not buy a better score, a higher position, or the removal of a single criticism. Our rating method and full disclosure are both public.
Both sell tirzepatide. Noom Med costs $149 a month and Hims & Hers costs $238, a difference of $89 a month or about $1,068 a year. The other differences matter more than the money if this is your first course.
Noom Med is behaviour change alongside medication. Hims & Hers is widest range of formats. They are not aimed at the same person, and the cheaper one is not automatically the right answer — particularly if this is your first course and you expect a slow titration.
What this means for your titration. Both price the same way as your dose climbs, so the gap between them stays constant the whole way up the ladder.
Side by side
| Noom Med | Hims & Hers | |
|---|---|---|
| Advertised from | $149 | $199 |
| Membership on top | None | $39/mo |
| True monthly cost | $149 | $238 |
| Roughly, per year | $1,788 | $2,856 |
| Price includes medication | Yes, at microdoses | Yes |
| Names its pharmacy | Not published | Not published |
| Our score | 3.5 / 5 | 3.5 / 5 |
Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.
The differences that affect treatment
They differ on 3 of the 7 things we track, and behave the same on the other 4. The differences are what the price gap is actually buying.
| Noom | Hims & Hers | |
|---|---|---|
| Offers an oral or sublingual option | No | Yes |
| Can dispense FDA-approved branded medication | No | Yes |
| Medication included in the monthly price | No | Yes |
What each programme publishes: Noom Med
- Noom Med listed from $149/month.
- Microdose GLP-1Rx programme listed from $79/month with medication included.
- Programme pairs low-dose medication with biomarker monitoring and coaching.
Where it wins: The coaching is the actual product here and it is well built. Watch for: A $79 microdose programme is not the same treatment as 10 mg tirzepatide. Check the dose before comparing on price.
What each programme publishes: Hims & Hers
- Weight-loss membership advertised at $39 for the first month.
- Compounded GLP-1 injections priced from $199/month.
- Oral medication kits priced from $79/month.
- Branded Zepbound offered at $1,899/month.
- Company has announced oral semaglutide pricing starting around $49/month, with the 1.5 mg dose around $149/month.
Where it wins: One account covers oral, compounded injectable and branded options. Watch for: The advertised entry prices and the membership are separate charges. Add $39/month to whatever medication figure you were quoted.
Strengths of each
Noom Med.
- The coaching is the actual product here and it is well built.
- Medication is included in the microdose tier rather than billed separately.
- Straightforward cancellation.
Hims & Hers.
- One account covers oral, compounded injectable and branded options.
- Large enough to keep supply steady when smaller sellers run dry.
- Branded Zepbound is available without leaving the platform.
How they score
| What we weigh | Weight | Noom | Hims & Hers |
|---|---|---|---|
| True monthly cost | 30% | 3.6 | 3.4 |
| Price honesty | 20% | 3.2 | 3.2 |
| Clinical support | 20% | 3.8 | 3.6 |
| Pharmacy sourcing | 15% | 3.3 | 3.9 |
| Cancelling | 15% | 3.6 | 3.3 |
Noom Med scores higher overall at 3.5 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.
Which suits you
- Pick Noom Med if cost is the binding constraint. Over a year the gap is about $1,068, which is real money for the same class of medication.
- Pick Hims & Hers if what it does better matters to you — one account covers oral, compounded injectable and branded options.
- Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.
The verdict
For most people starting out, Noom Med at $149 a month is the more defensible choice on arithmetic alone. Hims & Hers earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Noom Med and Hims & Hers.
How they sit against everyone else
| Programme | Per month | Dose-price | Our score |
|---|---|---|---|
| Coreage Rx Best overall on true monthly cost | $199 | Flat | 4.5 |
| Trimi Lowest flat price with named pharmacies | $125 | Varies | 4.6 |
| PlexusDx Pharmacy transparency and genetic testing | $189 | Varies | 4.4 |
| Ozari Health Lowest advertised semaglutide price | $125 | Varies | 4.4 |
| Fifty 410 Prepaid blocks with no subscription | $133 | Varies | 4.2 |
| Ivím Health Unlimited clinician access | $199 | Varies | 4 |
| Mochi Health Insurance concierge support | $278 incl. $79 fee | Varies | 3.6 |
| Coby Health Multi-month value with supplies included | $239 | Varies | 3.6 |
| Hims & Hers Widest range of formats | $238 incl. $39 fee | Varies | 3.5 |
| Ro Branded medication with insurance help | $448 incl. $149 fee | Varies | 3.5 |
| Zealthy Low-cost entry with insurance routing | $216 | Varies | 3.5 |
| LifeMD Insurance coordination | $149 | Varies | 3.5 |
Read next
- Noom Med tirzepatide review
Behaviour change alongside medication. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $149 a month.
- Hims & Hers tirzepatide review
Widest range of formats. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $238 a month.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- The twelve-month cost
Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.
- Best programmes if this is your first time
Ranked on how they price the dose ladder and how reachable support is — the two things that decide whether a beginner stays on treatment.
